EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-MetaanalyseOpen Access · CC BY-NC-ND 4.0

Comparative efficacy and safety of combined pharmacotherapy for posttraumatic stress disorder in military personnel: a systematic review and network meta-analysis

Oleg I. Belous, Seyran A. Gergokov, Ivan S. Klimov

Humanitarian Military Journal · 20.10.2026 · 2 (3) · 275-290

DOI: 10.17816/hmj716650 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Humanitarian Military Journal, online erschienen am 20.10.2026. Verfasst von Oleg I. Belous und 2 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Posttraumatic stress disorder in military personnel and veterans remains one of the most challenging medical and social problems. Standard therapy—selective serotonin reuptake inhibitors and trauma-focused psychotherapy—does not provide a clinically significant response in 40%–60% of patients, which in real practice leads to the widespread use of combined regimens. The evidence base for most of these prescriptions remains fragmentary, and direct comparative studies of various augmentation strategies in military personnel have been lacking until now. AIM: To systematize data from randomized controlled trials on various augmentation regimens for posttraumatic stress disorder in military personnel and veterans, to conduct a network meta-analysis, and to propose a clinically applicable algorithm for drug selection based on the dominant symptomatic cluster. METHODS: A systematic review and network meta-analysis of 18 randomized controlled trials with a total sample of more than 2500 patients were performed. The comparative efficacy (standardized mean difference, SMD) and safety (drop-out rate, adverse events) of augmenting agents added to baseline therapy with selective serotonin reuptake inhibitors were assessed. RESULTS: The greatest effect size was recorded for the combination of sertraline with prazosin (SMD = −0.61; sustained response over 12 weeks), which makes this strategy a priority for patients with severe sleep disturbances and nightmares. Risperidone augmentation showed a moderate effect (SMD = −0.38) with a high rate of metabolic and extrapyramidal complications (drop-out rate up to 32%). Data on olanzapine and memantine are preliminary, and their routine use is not recommended. The largest randomized controlled trial did not confirm an additive effect when sertraline was combined with prolonged exposure therapy—no differences from monotherapy were found. For ketamine, aripiprazole, topiramate, pregabalin, riluzole, and rivastigmine, the data are limited or contradictory, which precludes their recommended use outside a research context. CONCLUSION: The efficacy of combination therapy is achieved only with a phenotype-based approach. Unsystematic polypragmasy has no evidence of effectiveness and is associated with an increased risk of adverse events. The proposed algorithm allows structuring the choice of an augmenting agent depending on the residual phenotype: for sleep disturbances, prazosin; for explosive aggression, risperidone with mandatory metabolic monitoring; for cognitive-affective disorders, memantine remains a research option.

Zitieren

APA

Belous, O. I., Gergokov, S. A., & Klimov, I. S. (2026). Comparative efficacy and safety of combined pharmacotherapy for posttraumatic stress disorder in military personnel: a systematic review and network meta-analysis. Humanitarian Military Journal, 2(3), 275-290. https://doi.org/10.17816/hmj716650

Vancouver

Belous OI, Gergokov SA, Klimov IS. Comparative efficacy and safety of combined pharmacotherapy for posttraumatic stress disorder in military personnel: a systematic review and network meta-analysis. Humanitarian Military Journal. 2026;2(3):275-290. doi:10.17816/hmj716650

BibTeX
@article{Belous2026,
  author = {Belous, Oleg I. and Gergokov, Seyran A. and Klimov, Ivan S.},
  title = {Comparative efficacy and safety of combined pharmacotherapy for posttraumatic stress disorder in military personnel: a systematic review and network meta-analysis},
  journal = {Humanitarian Military Journal},
  year = {2026},
  volume = {2},
  number = {3},
  pages = {275--290},
  doi = {10.17816/hmj716650}
}
Kostenlos starten →